胃旁路术后体重反弹仍维持糖尿病缓解:长期代谢获益
回顾性分析224例Roux-en-Y胃旁路术(RYGB)和46例袖状胃切除术(SG)患者,比较体重反弹后持续糖尿病缓解率。RYGB组总体持续缓解率为75%,显著高于SG组的34.8%(p<0.001)。体重反弹与2型糖尿病复发无关。
要点
- RYGB术后持续糖尿病缓解率为75%,SG组为34.8%(p<0.001)。
- SG术后2型糖尿病复发风险约为RYGB的5.5倍。
- 体重反弹未与2型糖尿病复发相关,基线胰岛素使用、较高糖化血红蛋白及较长糖尿病病程与复发相关。
核心结论
- RYGB术后2型糖尿病缓解率在体重反弹情况下仍得以维持,提示RYGB可能通过旁路 proximal 小肠产生不依赖于体重减轻的代谢获益。
研究设计与样本
- 回顾性综述,纳入接受初次RYGB或SG、BMI≥35 kg/m²且术前诊断为2型糖尿病的患者,排除随访不足5年、无体重反弹或最低体重时未获2型糖尿病缓解者,最终分析224例RYGB和46例SG患者。
主要发现
- RYGB组总体持续糖尿病缓解率为75%,SG组为34.8%(p<0.001)。
- SG术后2型糖尿病复发风险约为RYGB的5.5倍。
- 持续糖尿病缓解率按体重反弹四分位分层:<25%组为85.5%,25%至44.9%组为81.7%,45%至74.9%组为63.2%,>75%组为60%。
- 基线胰岛素使用、较高术前糖化血红蛋白及较长术前2型糖尿病病程与2型糖尿病复发相关,而体重反弹未显示相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Roux-en-Y gastric bypass (RYGB) demonstrates high rates of type 2 diabetes mellitus (T2DM) remission, a phenomenon hypothesized to be mediated mainly by weight loss. Compared with procedures that do not bypass the proximal small intestines, such as sleeve gastrectomy (SG), RYGB exhibits weight loss-independent intestinal mechanisms conducive to T2DM remission. We investigated continued diabetes remission (CDR) rates despite weight recurrence (WR) after RYGB compared with an SG cohort. STUDY DESIGN: A retrospective review of patients who underwent successful primary RYGB or SG with a BMI value of 35 kg/m 2 or more and a preoperative diagnosis of T2DM was performed. Patients with less than 5 years of follow-up, absence of WR, or lack of T2DM remission at nadir weight were excluded. After selecting the optimal procedure for glycemic control, rates of CDR were then stratified into WR quartiles and compared. RESULTS: A total of 224 RYGB and 46 SG patients were analyzed. The overall rate of CDR was significantly higher in the RYGB group (75%) compared with the SG group (34.8%; p < 0.001). The odds of T2DM recurrence were 5.5 times higher after SG compared with RYGB. Rates of CDR were stratified into WR quartiles (85.5%, <25%; 81.7%, 25% to 44.9%; 63.2%, 45% to 74.9%; and 60%, >75%). Baseline insulin use, higher preoperative glycosylated hemoglobin, and longer preoperative duration of T2DM were associated with T2DM recurrence, whereas WR was not. CONCLUSIONS: T2DM remission rates after RYGB are maintained despite WR, arguing for a concurrent weight loss-independent metabolic benefit likely facilitated by bypassing the proximal small intestine.
引用
- Ghanem OM, Abi Mosleh K, Kerbage A, et al. Continued Diabetes Remission Despite Weight Recurrence: Gastric Bypass Long-Term Metabolic Benefit. J Am Coll Surg. 2024. PMID: 38349010. doi:10.1097/XCS.0000000000000934
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。